Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Nov 25, 2016 5:09pm
134 Views
Post# 25515679

RE:RE:RE:Suggested Pay-cut

RE:RE:RE:Suggested Pay-cut
Bunge wrote: Briacell apparently did it.

They did PP in August.

With clinical trials so close they decided to make a personal sacrifice and hold off burning shareholders again.

Actually thought it quite noble.

Knew you wouldn't agree. Don't know why as you were burned along with the rest of us.

With 6M shares and 3M options I think it would have been a good move for Roger to shave his $300,000/yr salary (along with the share/option rich Board) and hold off last PP for 3 or 4 months. Especially considering the 24 month hi/low of 78/17.

So shoot me.


Well said. Trump would like to take $1 's yearly salary. If RW is so confident he should consider your suggestions to cut his salary. If he doesn't want to cut his salary he could also consider to convert some part of the salary to TLT shares . ( for example at the current 25 cents level, 2500$ is about 10k shares. ..) I think you find out a great idea for the company's future development. I CAN'T AGREE WITH YOU MORE REGARDING THAT.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities